I Missed My Eye Injection Appointment: Does That Actually Matter?
Does a Missed Injection Actually Matter?
How long you have gone is only half the question. What your vision has done since is the other half. Call your eye doctor the same day, or go to the emergency room if you cannot reach them, if since your missed appointment you have noticed:
- A sudden loss of vision in the treated eye.
- A new dark or blank patch in the middle of your sight.
- Straight lines looking bent, wavy, or broken.
- A sudden shower of new floaters, or new flashing lights.
- A curtain or shadow across part of your vision.
These do not mean the damage is done. They mean the question is now urgent rather than routine, and your team would much rather hear from you today than find out at a rebooked visit in six weeks.
A few weeks is a different thing from several months, and the evidence separates them. Among 99 eyes whose injections slipped by at least three weeks, with an average slip of 44 days, vision was measurably worse at the first visit back, and the retina thicker, yet by 16 weeks neither difference remained1. By contrast, among 169 people treated between 2010 and 2022, those away for more than 6 months had significantly worse vision at their final visit than those away for 2 to under 6 months, whose final reading was the same as that of people who attended continuously2.
Rebook before you finish reading, if you can. That single action matters more than any explanation you might prepare. If your vision has changed, say so on the call, because that moves you into a different queue. If you cannot get an appointment as soon as you want, ask to be put on a cancellation list and ask what the wait actually is. Do not wait for the clinic to chase you.
Missing appointments is common, and the reasons are usually practical rather than careless. In one clinic cohort of 9,007 people on these injections, about 22 of every 100 had a gap of more than 12 months3. Retina teams see this every week. Coming back after a long gap is a good outcome from their point of view, not an awkward one, so embarrassment is the worst possible reason to stay away.
What a Gap in Treatment Actually Is
The medicine controls leaking blood vessels rather than removing them, and its effect wears off. The interval you were given is your team's estimate of how long your eye stays dry between doses. That is why the date is not arbitrary and why a gap is not simply a postponed appointment. It is a stretch of time in which the eye may be unprotected, and the length of that stretch is what matters most.
A slip is a few weeks, usually recoverable, and usually handled by getting back on schedule. A stop is months, and it is the pattern behind most of the poor outcomes in the research. The gap length that separated worse long term vision from unchanged vision in one study was six months2. That is one study rather than a rule, but it is a useful way to think about where you sit.
You are not unusual, and the numbers make that plain. Of 1,328 people who started these injections at one hospital, 348, about 26 of every 100, had stopped attending within the study period, and about half had stopped by 5 years4. Of those who stopped, roughly 6 of every 100 had been automatically discharged after missing appointments and about 5 of every 100 had simply never been sent one4.
Why Appointments Get Missed
The most common reason is not forgetfulness. In a survey of 100 people who missed an injection appointment, another illness was the reason in 39 of every 1005. Ill health preventing attendance accounted for about 14 of every 100 people who stopped attending in a separate hospital review4. If you are frequently unwell, tell the clinic, because that is a scheduling problem they can sometimes design around.
Transport and company are practical barriers, not excuses. Among people who missed an appointment, 73 of every 100 said they needed someone to accompany them, and 74 of every 100 lived outside the hospital's city5. Living more than 30 miles from the clinic was associated with higher odds of a long gap in one large cohort3. Ask the clinic what transport help exists locally. Many have a list they never think to offer.
Administrative problems are a bigger cause than most people expect. An administrative or bureaucratic problem was the reason in 28 of every 100 missed appointments in that survey, and people scheduled for the licensed eye drugs missed appointments for want of financial approval in 28 of every 100 cases, against 10 of every 100 scheduled for the off-label drug5. Lower income was also associated with higher odds of a long gap3.
Both are common and both are worth saying out loud. About half of people who missed an appointment reported moderate to severe anxiety about the injection, and 22 of every 100 believed the treatment was not working, although 53 of every 100 felt their vision had improved5. Anxiety about the needle can often be reduced with different numbing or a different technique. Tell the team rather than quietly stopping.
What a Gap Feels Like, and What It Hides
When a treated eye becomes active again, the usual first signs are distortion, a blurred or missing patch in the center of vision, or reading becoming harder than it was a month ago. Colors can look washed out. Straight edges, like door frames and window bars, are where distortion shows up first. Any of these after a gap is a reason to call rather than to wait for your rebooked date.
Two things hide change. Your other eye fills in the gap so well that a real loss in one eye can go unnoticed for months. And fluid can build up under the retina before it crosses into the part of your vision you actually use. In one large cohort, people with disease in only one eye had higher odds of a long gap than people with both eyes affected3, which fits how easily a good fellow eye masks a problem.
Cover one eye, look at something with straight lines, and compare it with the other eye. Do it in good light with your reading glasses on. Write down what you find and the date. Doing this before you call gives the office something concrete to triage, and it gives your doctor a rough timeline of when the change started, which is genuinely useful at the catch-up visit.
What Happens at the Catch-Up Visit
Expect a scan of the retina, taken the same way as before, so today can be laid against your previous images. It shows fluid and thickening directly, including changes you would not have noticed. This is usually what decides whether you restart at your old interval or a shorter one. Ask to see it next to your last one, since the comparison is easier to understand than the numbers.
Your vision is measured on the chart, one eye at a time, and compared with your reading before the gap. A drop is information rather than a verdict. Some of what is lost after a gap comes back once treatment restarts and the fluid clears, and some does not, which is why your doctor will want to measure again after the first few injections rather than judging from one visit.
You will be asked when you last had an injection, what you have noticed, and what got in the way. That last question is not a reproach. It is how the plan gets adjusted, whether that means a different appointment time, help with transport, or sorting out an approval before it lapses. Answer it honestly, including the practical and financial parts.
Getting Back on Track
Restarting is normal and your team will have done it many times. What the restart looks like depends on what the scan shows and how long you were away, and it is a judgment for your own retina specialist rather than something to work out in advance. Ask two things: what the plan is for the next three months, and what they expect to see change first.
Ask whether anything about the schedule can be adjusted to fit your life, because a plan you can actually keep beats a stricter one you cannot. Questions worth raising include whether appointment times can be grouped with other clinic visits, whether a closer site is possible, and whether the interval between injections could safely be different. The answers depend on your eye, but the questions are always reasonable.
Book the next appointment before you leave the building. Put it in your phone with a reminder a week ahead, so there is time to arrange a ride. Tell whoever brings you as soon as you have the date. If money or approvals were the problem last time, raise that at this visit rather than the week before the next one, since those things take time to arrange.
What the Evidence Says About Gaps
Short slips look recoverable in the research so far. In the study of 99 delayed eyes, vision and retinal thickness were both worse at the first visit after an average 44 day delay, and both had returned to match the comparison group by 16 weeks1. That is reassuring about a single missed appointment. It says nothing about repeated ones, and it was one group of patients in one condition.
Longer absences are where the outcomes diverge. Among 169 people, those away for over 6 months finished at 1.12 on the logMAR scale, on which a higher number means worse sight, against 0.65 for both the shorter gap group and the group who never missed a visit. Their vision had declined over the study while the other two groups held steady or improved, and no recovery was documented2. In the larger cohort, about 93 of every 100 people who were lost to follow up never came back at all3. Coming back is the variable you control.
All of these are observational studies, not trials, so they describe what happened to groups rather than what will happen to you. People with longer gaps may differ from people without them in ways the studies could not measure. What the numbers support is a direction rather than a prediction: shorter gaps look better than longer ones, and returning looks better than not returning.
When to Call, and How Fast
Treat it as this week's task rather than this month's. If your vision has changed at all since the missed appointment, treat it as today's. There is no threshold you have to cross before you are allowed to ring, and no gap so long that calling stops being worthwhile. The research is clear on the direction even where it cannot give you a personal answer.
Give the office four facts: which eye is treated, roughly when your last injection was, whether your vision has changed, and how suddenly. Say if you have noticed distortion or a new dark patch, because those words matter for triage. If you are told the next opening is months away, say what you have noticed and ask whether that changes the urgency.
Being discharged after missed appointments does not mean you cannot come back. In one hospital review, about 6 of every 100 people who stopped attending had been automatically discharged after missing appointments4. Ring the clinic and explain that you were on injections and want to be seen again. If they cannot take you back directly, ask your primary care doctor or optometrist for a fresh referral, and say that treatment was interrupted.
Questions People Ask After Missing an Injection
Almost certainly not. In a study of eyes delayed by an average of 44 days, the vision lost during the delay had recovered to match undelayed eyes by 16 weeks1. One missed appointment is a common event with a straightforward fix, which is to rebook. The pattern linked with worse outcomes in the research is months away, not one skipped date, and even then the useful next step is the same.
There is no clean cutoff, but the research offers a marker. In one study the group away for more than 6 months had significantly worse final vision, while the group away for 2 to under 6 months did as well as those who never missed a visit2. Treat six months as a warning line rather than a deadline, and understand that a shorter gap is always better than a longer one.
Some may, and nobody can promise your own result. After short delays averaging 44 days, the difference in vision had gone by 16 weeks1, while in the group away for more than 6 months no recovery of vision was documented2. What recovers depends on whether the change was fluid, which often settles with treatment, or scarring, which does not. Your scan is what tells your doctor which one you have.
Yes, and feeling fine is the reason this catches people out. Your better eye compensates so effectively that substantial loss in one eye can pass unnoticed. Fluid can also collect before it reaches the part of the retina you read with. The scan finds both long before you would. Feeling fine is a reason to keep the appointment relaxed, not a reason to skip it.
No, and this worry keeps people away far longer than the original problem did. In one cohort about 22 of every 100 patients had a gap of over 12 months3, so your clinic deals with this constantly. The team's interest is in what your eye looks like now and what would make the next appointment easier to keep. Nothing about that conversation requires an apology.
Only if your vision is unchanged and the wait is short. If you have noticed any change, call now instead, because the timing of treatment is exactly what your team is trying to get right. If your next slot is months away and you have already had a gap, ring and say so. The appointment you were given was planned around a schedule you have already come off.
More Questions About Interrupted Injection Treatment
Then the reason is the thing to fix, and it is fixable more often than people assume. In one survey of 100 people who missed an injection appointment, the reason they gave was another illness in 39 of every 100 and an administrative or bureaucratic problem in 28 of every 100, and separately 73 of every 100 said they needed someone to accompany them5. Each of those has a practical answer: a different appointment time, sorting an approval early, coordinating with your other medical care, or arranging company and transport in advance. Tell the clinic the actual reason.
Raise it rather than acting on it alone. Among people who missed appointments, 22 of every 100 believed the treatment was not working, while 53 of every 100 felt their vision had improved5. Injections often hold vision steady rather than improving it, so stability can feel like failure while actually being the goal. Ask your doctor what the treatment is aiming to do in your case and how they judge whether it is achieving it.
The general principle holds: these are scheduled treatments whose effect wears off, so gaps carry risk and rebooking promptly is the right move. The specific evidence quoted on this page comes from studies of wet macular degeneration. How much a gap matters for diabetic swelling or a retinal vein blockage is a question for your own retina specialist, who knows which condition you are being treated for and how active it has been.
Say so early, because cost is a recognized cause of missed treatment rather than a private failing. Lack of financial approval was behind 28 of every 100 missed appointments for the licensed eye drugs in one survey, compared with 10 of every 100 for the off-label drug5, and lower income was associated with higher odds of a long gap in a large cohort3. Ask the office about assistance programs and about lower cost options.
- What does my scan show now compared with before the gap?
- Is the change you can see fluid that may settle, or scarring that will not?
- What is the plan for the next three months, and what should I notice first?
- What is my vision measurement today, so we have a baseline to compare against?
- Which specific changes should make me call the same day rather than wait?
- What can be changed about the schedule, the location, or the cost to make this easier to keep?
- Scientific Reports; retrospective cohort study of unplanned anti-VEGF injection delays (2023). The effect of a brief, unplanned treatment delay on neovascular age-related macular degeneration patients: a retrospective cohort study.
- Graefe's Archive for Clinical and Experimental Ophthalmology; retrospective comparative study of patients treated 2010 to 2022 (2025). Long-term visual outcomes of patients with neovascular age-related macular degeneration treated with anti-VEGF therapy lost to follow-up.
- JAMA Ophthalmology; retrospective cohort study at an urban private retina practice, April 2012 to January 2016 (2018). Loss to Follow-up Among Patients With Neovascular Age-Related Macular Degeneration Who Received Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
- Eye (London); retrospective review of electronic medical records at a UK NHS hospital, January 2014 to December 2018 (PubMed Central PMC10564721) (2023). Disengagement and loss to follow-up in intravitreal injection clinics for neovascular age-related macular degeneration.
- Ophthalmic Research; cross-sectional survey of patients who missed scheduled intravitreal injection appointments at a tertiary centre (2025). Exploring Factors behind Patient Nonadherence to Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Macular Diseases.